Neuropeptide Y Y5 receptor antagonists
The present invention discloses compounds which, are novel receptor antagonists for NPY Y5 as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such NPY Y5 receptor antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.
Schering-Plough Corporation
A C C C A C A A A A C
A61P C07D C07D C07D A61P C07D A61P A61P A61P A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Ying Guoqing Andrew W.
Huang Li Stamford